Trypanocidal and leishmanicidal activities of different antimicrobial peptides (AMPS) isolated from aquatic animals

被引:87
作者
Loefgren, S. E. [1 ]
Miletti, L. C. [2 ]
Steindel, M. [3 ]
Bachere, E. [4 ]
Barracco, M. A. [1 ]
机构
[1] Univ Fed Santa Catarina, Dept Biol Celular Embriol & Genet, Lab Imunol Aplicada Aquicultura, Ctr Ciencias Biol, BR-88040900 Florianopolis, SC, Brazil
[2] Univ Fed Santa Catarina, Dept Bioquim, Florianopolis, SC, Brazil
[3] Univ Fed Santa Catarina, Dept Microbiol & Parasitol, Florianopolis, SC, Brazil
[4] Univ Montpellier 2, IFREMER, CNRS, Montpellier 5, France
关键词
animal antimicrobial peptides; antiparasitic activity; Trypanosoma cruzi; Leishmania braziliensis; MTT, 3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromide; LD50; lethal dose for 50% of parasites;
D O I
10.1016/j.exppara.2007.07.011
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Most of the available animal antimicrobial peptides (AMPs) have been tested against bacteria and fungi, but very few against protozoan parasites. In the present study, we investigated the antiparasitic activity of different AMPs isolated from aquatic animals: tachyplesin (Tach, from Tachypleus tridentatus), magainin (Mag, from Xenopus laevis), clavanin (Clav, from Styela clava), penaeidin (Pen, from Litopenaeus vannamei), mytilin (Myt, from Mytilus edulis) and anti-lipopolysaccharide factor (ALF, from Penaeus monodon). The antiparasitic activity was evaluated against the promastigote form of Leishmania braziliensis and epi and trypomastigote forms of Trypanosoma cruzi, through the MTT method. Tach was the most potent peptide, killing completely L. braziliensis and trypomastigote T cruzi from 12.5 mu M, whereas Pen and Clav were weakly active against trypomastigotes and Myt against L. braziliensis, only at a high concentration (100 mu M). Tach and Mag were markedly hemolytic at high concentrations, whereas the other peptides caused only a slight hemolysis (< 10% up to 50 mu M). Our results point to Tach as the only potential candidate for further investigation and potential application as a therapeutic agent. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:197 / 202
页数:6
相关论文
共 30 条
[1]   Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis [J].
Alberola, J ;
Rodríguez, A ;
Francino, O ;
Roura, X ;
Rivas, L ;
Andreu, D .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) :641-643
[2]   Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitemias in mice [J].
Barr, SC ;
Rose, D ;
Jaynes, JM .
JOURNAL OF PARASITOLOGY, 1995, 81 (06) :974-978
[3]   Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides [J].
Bera, A ;
Singh, S ;
Nagaraj, R ;
Vaidya, T .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2003, 127 (01) :23-35
[4]   Dermaseptins from Phyllomedusa oreades and Phyllomedusa distincta -: Anti-Trypanosoma cruzi activity without cytotoxicity to mammalian cells [J].
Brand, GD ;
Leite, JRSA ;
Silva, LP ;
Albuquerque, S ;
Prates, MV ;
Azevedo, RB ;
Carregaro, V ;
Silva, JS ;
Sá, VCL ;
Brandao, RA ;
Bloch, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (51) :49332-49340
[5]   Antimicrobial peptides: Pore formers or metabolic inhibitors in bacteria? [J].
Brogden, KA .
NATURE REVIEWS MICROBIOLOGY, 2005, 3 (03) :238-250
[6]   Anti-microbial peptides:: from invertebrates to vertebrates [J].
Bulet, P ;
Stöcklin, R ;
Menin, L .
IMMUNOLOGICAL REVIEWS, 2004, 198 :169-184
[7]  
BULET P, 1993, J BIOL CHEM, V268, P14893
[8]  
CARRIELGOMES MC, 2001, MEMORIAS I OSWALDO C, V102, P469
[9]   Innate immunity - Isolation of several cysteine-rich antimicrobial peptides from the blood of a mollusc, Mytilus edulis [J].
Charlet, M ;
Chernysh, S ;
Philippe, H ;
Hetru, C ;
Hoffmann, JA ;
Bulet, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (36) :21808-21813
[10]   N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide [J].
Chicharro, C ;
Granata, C ;
Lozano, R ;
Andreu, D ;
Rivas, L .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2441-2449